DOP02: Supplementation with butyrate producing bacteria reduces tumour load in a mouse model of colitis-associated cancer
ECCO '19 Copenhagen
2019
DOP03: The correlation of regulatory miRNAs with cytokine serum levels and cytokine genes’ polymorphisms
ECCO '19 Copenhagen
2019
DOP04: The ability of epithelial regeneration is reduced in the Crohn’s disease patient-derived organoids, especially in TNF-α enriched condition
ECCO '19 Copenhagen
2019
DOP05: Adipose-derived stem cells from Crohn’s disease patients show antigen presenting cell-like properties
ECCO '19 Copenhagen
2019
DOP06: Dynamic shifts in the balance of gut homing Treg and Th17 cells play a critical role in ulcerative colitis and may predict response to vedolizumab therapy
ECCO '19 Copenhagen
2019
DOP07: IMP761, a novel anti-LAG-3 agonist antibody for the treatment of auto-immune diseases
ECCO '19 Copenhagen
2019
DOP08: The regulatory landscape of intestinal cells—investigating the transcriptional effect of autophagy impairment observed in Crohn’s disease using organoid and network biology approaches
ECCO '19 Copenhagen
2019
DOP09: Interleukin-20 subfamily cytokines in controlling intestinal inflammation and epithelial barrier integrity
ECCO '19 Copenhagen
2019
DOP10: Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease
ECCO '19 Copenhagen
2019
DOP11: Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis
ECCO '19 Copenhagen
2019
DOP12: Mutations in the X-linked inhibitor of apoptosis protein promote susceptibility to microbiota-induced intestinal inflammation
ECCO '19 Copenhagen
2019
DOP13: Immune profiling of adipose tissue in murine models of inflammatory bowel disease (IBD)
ECCO '19 Copenhagen
2019
DOP14: TiO2 nanoparticles abrogate the protective effect of the autoimmunity-associated PTPN22R619W variant during acute DSS colitis
ECCO '19 Copenhagen
2019
DOP15: Metabolomics coupled with pathway analysis characterise metabolic changes in treatment-naive ulcerative colitis patients
ECCO '19 Copenhagen
2019
DOP16: Endoplasmic reticulum stress in subepithelial myofibroblasts increases the TGF-β1 activity that regulates fibrosis in Crohn’s disease
ECCO '19 Copenhagen
2019
DOP17: AZD4205, a potent, GI tract-enriched, JAK1-selective inhibitor for treatment of inflammatory bowel disease (IBD)
ECCO '19 Copenhagen
2019
DOP18: OSM neutralisation in IBD mucosal explant cultures reduces pro-inflammatory cytokine production
ECCO '19 Copenhagen
2019
DOP20: Drugs that modulate histone acetylation disrupt TGF-β-signalling and reduce collagen I expression in models of stricturing Crohn’s disease
ECCO '19 Copenhagen
2019
DOP22: UC-related and segment-specific properties of patient-derived colonic organoids
ECCO '19 Copenhagen
2019